Assessment of Perampanel (E2007) on Synaptic Dopamine in Mild-moderate PD Patients: A Pilot Study With [^123I]-IBZM SPECT
Clinical trial NCT00566462 · TERMINATED
Trial details
- NCT number
- NCT00566462
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2008-12-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.